DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 3.661
EU - Europa 3.449
AS - Asia 1.547
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
OC - Oceania 3
Totale 8.673
Nazione #
US - Stati Uniti d'America 3.643
CN - Cina 809
UA - Ucraina 771
IE - Irlanda 634
TR - Turchia 554
GB - Regno Unito 481
SE - Svezia 453
FR - Francia 345
IT - Italia 343
DE - Germania 233
FI - Finlandia 144
IN - India 128
VN - Vietnam 32
RU - Federazione Russa 13
BE - Belgio 12
CA - Canada 11
IL - Israele 8
MX - Messico 7
CL - Cile 5
EU - Europa 4
RO - Romania 4
SG - Singapore 4
EG - Egitto 3
ES - Italia 3
IR - Iran 3
AU - Australia 2
CH - Svizzera 2
GR - Grecia 2
JP - Giappone 2
KR - Corea 2
PL - Polonia 2
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
HU - Ungheria 1
LB - Libano 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8.673
Città #
Jacksonville 841
Chandler 707
Dublin 631
Southend 387
Dearborn 382
Princeton 310
Izmir 263
Nanjing 250
Wilmington 173
Cambridge 140
Beijing 138
Altamura 98
Nanchang 78
Ann Arbor 73
Boardman 68
New York 68
Chieti 58
Woodbridge 54
Shenyang 47
Hebei 39
Ashburn 37
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 30
Tianjin 26
Hangzhou 20
Hefei 20
Houston 20
Jinan 19
Norwalk 18
Düsseldorf 17
Orange 16
Changsha 15
Guangzhou 14
Lanciano 12
Brussels 11
Chennai 11
Falls Church 11
Auburn Hills 10
Helsinki 10
Augusta 9
Leawood 9
Los Angeles 9
Pescara 9
Washington 9
Changchun 8
Lanzhou 8
Ningbo 8
San Mateo 8
Mexico City 6
Tappahannock 6
Toronto 6
Porto San Giorgio 5
Torino 5
Andover 4
Baotou 4
Padova 4
Rome 4
Shanghai 4
Taizhou 4
Xian 4
Zhengzhou 4
Jülich 3
Milan 3
Pune 3
Rouen 3
Seattle 3
Walnut 3
Bangalore 2
Campobasso 2
Catanzaro 2
Cedar Knolls 2
Collecorvino 2
Francavilla Al Mare 2
Fuzhou 2
Gradara 2
Harbin 2
Kocaeli 2
Montesilvano 2
Montesilvano Marina 2
Redmond 2
San Giovanni Teatino 2
Silver Spring 2
Simi Valley 2
Vasto 2
Wuhan 2
Acquaviva Picena 1
Ameno 1
Antwerp 1
Ardabil 1
Asunción 1
Aubonne 1
Auckland 1
Baltimore 1
Belgrade 1
Berlin 1
Birmingham 1
Bologna 1
Bucharest 1
Totale 5.428
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 94
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 91
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 87
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 85
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 84
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 83
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 83
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 83
Targeting tumor-related immunosuppression for cancer immunotherapy. 79
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 79
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 79
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 78
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 78
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 77
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 77
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 76
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 76
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 76
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 76
null 76
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 75
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 75
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 75
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 75
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 74
The role of B lymphocytes and NK cells in cardiac allograft rejection. 74
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 73
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 73
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 73
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 73
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 72
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 72
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 71
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 71
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 71
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 71
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 71
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 71
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 71
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 70
Neutrophils in anti-cancer immunological strategies: old players in new games 70
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 70
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 70
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 69
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 68
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 68
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 68
The Quilty Effect: an actor in search of a part 68
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 68
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 68
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 68
Immunological prevention of a multigene cancer syndrome. 67
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 67
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 67
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 67
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 66
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 66
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 66
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 66
The antitumor potential of Interleukin-27 in prostate cancer 66
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 66
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 66
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 65
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 65
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 65
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 65
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 65
Neutrophils in the antitumoral immune response 65
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 64
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 64
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 64
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 64
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 64
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 64
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 63
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 63
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 63
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. 63
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma. 62
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 62
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 62
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 61
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. 61
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 60
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 60
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice 59
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. 59
The Lack of IL-12Rbeta2 signaling in lung adenocarcinomas is a novel mechanism of tumor escape from immune surveillance 59
The IL-12Rb2 gene protects from autoimmunity and functions as tumor suppressor in B cell malignancies. 59
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers 59
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 59
Gene trasfer of a secretable form of il-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response 58
Mouse tumorigenesis models as an aid to understanding human cancer. 58
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 58
Different biological role and anti-tumor activity of interleukin-15 isoforms. 57
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 56
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 56
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 56
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 56
Endogenous IL-12 triggers an antiangiogenic program in melanoma cells. 55
Totale 6.871
Categoria #
all - tutte 29.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019314 0 0 0 0 0 0 0 0 0 0 4 310
2019/20202.083 586 127 6 92 148 256 308 219 44 93 178 26
2020/2021892 148 4 149 9 97 224 14 6 38 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.114 175 212 116 254 224 447 116 142 293 52 54 29
2023/2024723 77 35 48 20 36 247 232 15 1 12 0 0
Totale 9.172